We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3665:TWSEBizLink Holding Inc. Analysis

Data as of 2026-05-18 - not real-time

NT$2,025.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

BizLink Holding Inc. is currently trading in a bullish market environment with increasing volume, yet several technical signals suggest caution. The price is positioned above the short‑term moving average but remains below the medium‑term average, indicating that upward momentum is present but not fully confirmed. RSI is in the oversold territory, which could provide a short‑term catalyst for price appreciation, while the MACD histogram is negative, reflecting lingering bearish pressure. The stock is holding above a key support level and still has room before encountering the next resistance, offering a tactical entry point for risk‑aware investors. However, the computed beta exceeds one, pointing to heightened sensitivity to market swings, and the 30‑day volatility is markedly high, underscoring the potential for sharp price moves. Fundamentally, the price‑to‑earnings multiple is well above the industry average and the discounted cash‑flow valuation is far lower than the market price, suggesting the stock is significantly overvalued at present.
The company’s fundamentals remain robust, with strong revenue growth, solid operating margins, and a healthy cash position that comfortably covers its debt. Dividend yield is modest but the payout ratio is low, indicating that the dividend is sustainable. Forward earnings estimates imply a more reasonable valuation, and the business is well‑positioned in high‑growth segments such as electric‑vehicle wiring, data‑center connectivity, and medical equipment. Given the blend of technical oversold conditions, high valuation, and solid fundamentals, a cautious approach is advisable: consider a short‑term purchase on dips while planning to reassess as valuation metrics converge.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Oversold RSI indicating potential rebound
  • Price above key support with upside room
  • Increasing volume supporting bullish trend

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong revenue and earnings growth
  • Persistently high valuation relative to peers
  • Robust cash flow and manageable debt

Long Term

> 3 years
Neutral
Model confidence: 8/10

Key Factors

  • Strategic exposure to EV, data‑center, and medical markets
  • Sustainable dividend with low payout ratio
  • Potential valuation compression as market aligns with fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth29.40%
Profit Margin12.72%
P/E Ratio43.7
ROE23.14%
ROA11.03%
Debt/Equity37.64
P/B Ratio8.5
Op. Cash FlowNT$7.9B
Free Cash FlowNT$3.1B
Industry P/E29.4

Technical Analysis

TrendBullish
RSI35.5
SupportNT$1,990.00
ResistanceNT$3,010.00
MA 20NT$2,620.50
MA 50NT$2,179.10
MA 200NT$1,493.20
MACDBearish
VolumeIncreasing
Fear & Greed Index88.18

Valuation

Fair ValueNT$576.10
Target PriceNT$3,032.75
Upside/Downside49.77%
GradeOvervalued
TypeGrowth
Dividend Yield0.50%

Risk Assessment

Beta1.23
Volatility74.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.